In 2021, the Total Profit of China's Pharmaceutical Industry will Exceed 700 Billion Yuan, a Year-on-year Increase of 67.3%

On May 10, at the press conference of the National Development and Reform Commission on the "14th Five-Year Plan for Bioeconomic Development", Zhou Jian, deputy director of the Consumer Products Industry Department of the Ministry of Industry and Information Technology, introduced that in 2021, the main economic indicators of my country's pharmaceutical industry will show rapid growth. 

Specifically, in 2021, the added value of the pharmaceutical industry will increase by 23.1% year-on-year, and the growth rate will increase by 15.3 percentage points over the same period of the previous year, which is 13.5 percentage points higher than the overall growth rate of all industries. The proportion of the added value of the pharmaceutical industry in the total industrial added value continued to rise, accounting for 4.1%, and its role in stabilizing industrial economic growth was further enhanced. The operating income was 3,370.75 billion yuan, a cumulative year-on-year increase of 18.7%, an increase of 11.4 percentage points over the same period of the previous year, and the growth rate reached a new high in the past five years. The total profit achieved was 708.75 billion yuan, a year-on-year increase of 67.3%.